1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 MRSA 1.2.3 Streptococcus 1.2.4 TB and Drug-resistant TB 1.2.5 Gastro-intestinal Panel Testing 1.2.6 HIV 1.2.7 Hepatitis C 1.2.8 Others 1.3 Market by Application 1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Immunochemistry 1.3.3 Molecular Diagnostics 1.3.4 Microbiology 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2018-2029) 2.2 Infectious Diseases In Vitro Diagnostics Growth Trends by Region 2.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Size by Region (2018-2023) 2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2024-2029) 2.3 Infectious Diseases In Vitro Diagnostics Market Dynamics 2.3.1 Infectious Diseases In Vitro Diagnostics Industry Trends 2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers 2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges 2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue 3.1.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue (2018-2023) 3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2018-2023) 3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Infectious Diseases In Vitro Diagnostics Revenue 3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio 3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2022 3.5 Infectious Diseases In Vitro Diagnostics Key Players Head office and Area Served 3.6 Key Players Infectious Diseases In Vitro Diagnostics Product Solution and Service 3.7 Date of Enter into Infectious Diseases In Vitro Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type 4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2018-2023) 4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2024-2029) 5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application 5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2018-2023) 5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2018-2029) 6.2 North America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) 6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2018-2029) 7.2 Europe Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) 7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size (2018-2029) 8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2018-2023) 8.4 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size (2018-2029) 9.2 Latin America Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) 9.4 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size (2018-2029) 10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) 10.4 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 BD 11.1.1 BD Company Detail 11.1.2 BD Business Overview 11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction 11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.1.5 BD Recent Development 11.2 Abbott 11.2.1 Abbott Company Detail 11.2.2 Abbott Business Overview 11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction 11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.2.5 Abbott Recent Development 11.3 Alere 11.3.1 Alere Company Detail 11.3.2 Alere Business Overview 11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction 11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.3.5 Alere Recent Development 11.4 Quidel 11.4.1 Quidel Company Detail 11.4.2 Quidel Business Overview 11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction 11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.4.5 Quidel Recent Development 11.5 F. Hoffmann-La Roche 11.5.1 F. Hoffmann-La Roche Company Detail 11.5.2 F. Hoffmann-La Roche Business Overview 11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction 11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.5.5 F. Hoffmann-La Roche Recent Development 11.6 Orasure Technologies 11.6.1 Orasure Technologies Company Detail 11.6.2 Orasure Technologies Business Overview 11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction 11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.6.5 Orasure Technologies Recent Development 11.7 Cepheid 11.7.1 Cepheid Company Detail 11.7.2 Cepheid Business Overview 11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction 11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.7.5 Cepheid Recent Development 11.8 Hologic 11.8.1 Hologic Company Detail 11.8.2 Hologic Business Overview 11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction 11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.8.5 Hologic Recent Development 11.9 Qiagen 11.9.1 Qiagen Company Detail 11.9.2 Qiagen Business Overview 11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction 11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.9.5 Qiagen Recent Development 11.10 Bio-Rad Laboratories 11.10.1 Bio-Rad Laboratories Company Detail 11.10.2 Bio-Rad Laboratories Business Overview 11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction 11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.10.5 Bio-Rad Laboratories Recent Development 11.11 Siemens Healthcare 11.11.1 Siemens Healthcare Company Detail 11.11.2 Siemens Healthcare Business Overview 11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction 11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) 11.11.5 Siemens Healthcare Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of MRSA Table 3. Key Players of Streptococcus Table 4. Key Players of TB and Drug-resistant TB Table 5. Key Players of Gastro-intestinal Panel Testing Table 6. Key Players of HIV Table 7. Key Players of Hepatitis C Table 8. Key Players of Others Table 9. Global Infectious Diseases In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 10. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million) Table 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2018-2023) Table 13. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 14. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2024-2029) Table 15. Infectious Diseases In Vitro Diagnostics Market Trends Table 16. Infectious Diseases In Vitro Diagnostics Market Drivers Table 17. Infectious Diseases In Vitro Diagnostics Market Challenges Table 18. Infectious Diseases In Vitro Diagnostics Market Restraints Table 19. Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2018-2023) & (US$ Million) Table 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players (2018-2023) Table 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2022) Table 22. Ranking of Global Top Infectious Diseases In Vitro Diagnostics Companies by Revenue (US$ Million) in 2022 Table 23. Global 5 Largest Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue (CR5 and HHI) & (2018-2023) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Infectious Diseases In Vitro Diagnostics Product Solution and Service Table 26. Date of Enter into Infectious Diseases In Vitro Diagnostics Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Infectious Diseases In Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million) Table 29. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2018-2023) Table 30. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 31. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2024-2029) Table 32. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million) Table 33. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2018-2023) Table 34. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 35. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2024-2029) Table 36. North America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million) Table 38. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million) Table 39. Europe Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 40. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million) Table 41. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million) Table 42. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 43. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million) Table 44. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2024-2029) & (US$ Million) Table 45. Latin America Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million) Table 47. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million) Table 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 49. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million) Table 50. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million) Table 51. BD Company Detail Table 52. BD Business Overview Table 53. BD Infectious Diseases In Vitro Diagnostics Product Table 54. BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 55. BD Recent Development Table 56. Abbott Company Detail Table 57. Abbott Business Overview Table 58. Abbott Infectious Diseases In Vitro Diagnostics Product Table 59. Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 60. Abbott Recent Development Table 61. Alere Company Detail Table 62. Alere Business Overview Table 63. Alere Infectious Diseases In Vitro Diagnostics Product Table 64. Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 65. Alere Recent Development Table 66. Quidel Company Detail Table 67. Quidel Business Overview Table 68. Quidel Infectious Diseases In Vitro Diagnostics Product Table 69. Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 70. Quidel Recent Development Table 71. F. Hoffmann-La Roche Company Detail Table 72. F. Hoffmann-La Roche Business Overview Table 73. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product Table 74. F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 75. F. Hoffmann-La Roche Recent Development Table 76. Orasure Technologies Company Detail Table 77. Orasure Technologies Business Overview Table 78. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product Table 79. Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 80. Orasure Technologies Recent Development Table 81. Cepheid Company Detail Table 82. Cepheid Business Overview Table 83. Cepheid Infectious Diseases In Vitro Diagnostics Product Table 84. Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 85. Cepheid Recent Development Table 86. Hologic Company Detail Table 87. Hologic Business Overview Table 88. Hologic Infectious Diseases In Vitro Diagnostics Product Table 89. Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 90. Hologic Recent Development Table 91. Qiagen Company Detail Table 92. Qiagen Business Overview Table 93. Qiagen Infectious Diseases In Vitro Diagnostics Product Table 94. Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 95. Qiagen Recent Development Table 96. Bio-Rad Laboratories Company Detail Table 97. Bio-Rad Laboratories Business Overview Table 98. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product Table 99. Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 100. Bio-Rad Laboratories Recent Development Table 101. Siemens Healthcare Company Detail Table 102. Siemens Healthcare Business Overview Table 103. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product Table 104. Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2018-2023) & (US$ Million) Table 105. Siemens Healthcare Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Infectious Diseases In Vitro Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Infectious Diseases In Vitro Diagnostics Market Share by Type: 2022 VS 2029 Figure 3. MRSA Features Figure 4. Streptococcus Features Figure 5. TB and Drug-resistant TB Features Figure 6. Gastro-intestinal Panel Testing Features Figure 7. HIV Features Figure 8. Hepatitis C Features Figure 9. Others Features Figure 10. Global Infectious Diseases In Vitro Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 11. Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2022 VS 2029 Figure 12. Immunochemistry Case Studies Figure 13. Molecular Diagnostics Case Studies Figure 14. Microbiology Case Studies Figure 15. Others Case Studies Figure 16. Infectious Diseases In Vitro Diagnostics Report Years Considered Figure 17. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 18. Global Infectious Diseases In Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 19. Global Infectious Diseases In Vitro Diagnostics Market Share by Region: 2022 VS 2029 Figure 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players in 2022 Figure 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2022) Figure 22. The Top 10 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2022 Figure 23. North America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. North America Infectious Diseases In Vitro Diagnostics Market Share by Country (2018-2029) Figure 25. United States Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Canada Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Europe Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Europe Infectious Diseases In Vitro Diagnostics Market Share by Country (2018-2029) Figure 29. Germany Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. France Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. U.K. Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Italy Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Russia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Nordic Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Share by Region (2018-2029) Figure 37. China Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Japan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. South Korea Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. India Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Australia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Latin America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Latin America Infectious Diseases In Vitro Diagnostics Market Share by Country (2018-2029) Figure 45. Mexico Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Brazil Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Share by Country (2018-2029) Figure 49. Turkey Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million) Figure 51. BD Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 52. Abbott Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 53. Alere Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 54. Quidel Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 56. Orasure Technologies Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 57. Cepheid Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 58. Hologic Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 59. Qiagen Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 61. Siemens Healthcare Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2018-2023) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

BD Abbott Alere Quidel F. Hoffmann-La Roche Orasure Technologies Cepheid Hologic Qiagen Bio-Rad Laboratories Siemens Healthcare